A phase 3 trial of ST-01 in patients with chronic scrotal pain
Latest Information Update: 21 Jan 2026
At a glance
- Drugs ST 01 (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
Most Recent Events
- 21 Jan 2026 New trial record
- 08 Jan 2026 According to a Sustained Therapeutics media release, based on the results from previous phase 2 study results, company plans to proceed to Phase 3 trials in Canada and the United States, subject to regulatory approval.